Showing 2451-2460 of 9108 results for "".
All in One
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/all-in-one/18726/The Sciton Joule platform offers multiple treatment options to address multiple indications in a single, scalable system, making it a top laser platform pick for 2017, says Dr. Cohen during Cosmetic Surgery Forum.Biosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO BrentBuilding Your Brand with Google+
https://practicaldermatology.com/topics/practice-management/building-your-brand-with-google-/18612/Google+ can be an important marketing tool for practices. It helps produce faster crawling and indexing of web pages and faster link equity. Learn more about how this tool can help practices grow and get tips on optimizing your use of this social platform.Systemic Implications of Psoriasis
https://practicaldermatology.com/topics/psoriasis/systemic-implications-of-psoriasis/18636/Although a disease with a presentation on the skin, psoriasis has important implications for systemic health. Joel Gelfand, MD, talks about the increased risk for diabetes and cardiovascular disease in patients with psoriasis, as well as the clinician's role in educating patients about their diseaseUsing Pinterest for your Healthcare or Dental Practice
https://practicaldermatology.com/topics/practice-management/using-pinterest-for-your-healthcare-or-dental-practice/18650/There's a growing social media platform that can enhance your digital marketing program. Pinterested in learning more? Pinterest has quickly emerged as a new-age marketing tool for business. Learn more from The Ekwa Marketing team in this Ekwa.com educational video.ASDS BCC Recommendations; Bad Online Reviews for Derms
https://practicaldermatology.com/topics/practice-management/dermwiretv-asds-bcc-recommendations-bad-online-reviews-for-derms/18906/This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommendation for the management of Basal Cell Carcinoma (BCC). An expert panel found Mohs micrographic surgery is highly cost effective. In other news, researchers find that dermatologistKythera's Kybella Approved; ASLMS Update
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-kythera-s-kybella-approved-aslms-update/18925/FDA Approves Kythera's Kybella (ATX-101 or deoxycholic acid) injection for reduction of sub mental fullness or double chin. ASLMS Recognizes women in device-based medicine (Women in Energy-based Devices). Deka and Syneron get new clearances. ASDS Launches Skin Cancer PSAs, and Foamix sells shares.Tensage Natural Growth Factor
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tensage-natural-growth-factor/18938/Tensage®, the exclusive natural Growth Factor skin care line from Biopelle, uses advanced SCA biorepair technology to revitalize and restore skin that has been damaged by photoaging and dermatologic treatments.Atopic Dermatitis Guidelines Update
https://practicaldermatology.com/topics/general-topics/atopic-dermatitis-guidelines-update/18949/Peter Lio, MD speaks with Joel Cohen, MD about atopic dermatitis consensus recommendations, particularly the differences among different medical specialties. He also discusses how global guidelines may begin to take shape.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.